Deferred Tax Assets, Valuation Allowance of Repare Therapeutics Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Repare Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Repare Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $139,757,000, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Repare Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $139,757,000 +$28,204,000 +25% 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q4 2023 $111,553,000 +$14,513,000 +15% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q4 2022 $97,040,000 +$34,434,000 +55% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $62,606,000 +$27,248,000 +77% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $35,358,000 +$20,933,000 +145% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $14,425,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.